Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Influenza Vaccine
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Undisclosed
Sponsor : Sanofi
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : The study’s primary endpoint was to examine the difference in self-reported flu vaccination rates in people with diabetes who received a digital intervention and people with diabetes who did not.
Product Name : Undisclosed
Product Type : Vaccine
Upfront Cash : Inapplicable
September 29, 2021
Lead Product(s) : Influenza Vaccine
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Undisclosed
Sponsor : Sanofi
Deal Size : Inapplicable
Deal Type : Inapplicable
Reset All
